FIG 3.

Co-occuring mutations with METex14 and longitudinal ctDNA cases. (A and B) Volcano plots showing the difference of co-occurring alterations between METex14 NSCLC and non-METex14 NSCLC in (A) Guardant360 and (B) GenePlus data sets. (C) Cases with co-occurring alterations with METex14 were shown, and the gene with dominant clone was labeled by star. (D) Genomic alterations of longitudinal cases at different time for patients with METex14 NSCLC in Guardant360 (GH) and GenePlus (GP) data sets. METex14, MET exon 14 skipping alterations; NSCLC, non–small-cell lung cancer; TK, tyrosine kinase domain.